William's father, Thomas, had been born in County Galway, Ireland, and emigrated to Australia in the late nineteenth century. Tony's mother, Irene Broadstock, was born in Broken Hill in 1901. Tony was an only child and grew up in Clovelly, an eastern suburb of Sydney. William died when Tony was 11 years old. Tony did not have a close relationship with his father, who came from a strong Irish Catholic background. Tony rejected religious belief as he grew up.
After his father's death, Tony was the only male in the household, living with his mother, a maiden aunt and his dominating maternal grandmother. Tony was very close to his mother and, long after he first settled in Melbourne, she finally moved to a retirement home in Melbourne where she lived out her days until her passing in 1997.
Secondary and university education
Tony attended the Sydney Boys High School from 1942 to 1946. His interest in science was kindled by an outstanding chemistry teacher, Leonard Basser, who inspired many boys who went on to successful careers in science (he is reputed to have taught at least eight boys who became Fellows of the Royal Society, including Robert May (FRS 1979; PRS 2001 PRS -2005 ; Baron May of Oxford 2001), president of the Society, and John (later Sir John) Cornforth (FRS 1952) , who shared the Nobel Prize for chemistry in 1975). Tony completed his BSc at the University of Sydney in 1950, majoring in biochemistry and graduating with first class honours. In his honours year, he carried out research work with Eva Eden on carbon tetrachloride toxicity and its effects on creatine metabolism in rats. At university, Tony enjoyed competitive sports, including rugby and tennis.
Masters and PhD research studies (1951) (1952) (1953) (1954) (1955) (1956) Tony carried out research work towards his MSc, and subsequently his PhD degree under the supervision of Professor Jack Still, who was professor and head of biochemistry at the University of Sydney from 1949 to 1976. He enrolled initially for an MSc degree in Still's area of interest on bacterial pigment formation, studying metabolic aspects in Serratia marcescens, and submitted his MSc thesis in February 1954.
For his PhD studies, Tony took up the challenge of demonstrating that baker's yeast (Saccharomyces cerevisiae) contained mitochondria (organelles found in the cells of every complex organism which produce chemical energy in the form of adenosine triphosphate (ATP), which cells need to survive and prosper). This was an innovative project at the time, as it was not known if microorganisms, including bacteria and fungi, contained mitochondria. A strong hint that this yeast (already recognized as eukaryotic) contained a respiratory system had come from the pioneering genetic studies carried out in France by Boris Ephrussi and colleagues. They had already shown by 1951 that there were unusual 'petite' mutants of S. cerevisiae that were unable to respire and obligatorily used fermentable substrates such as glucose (Ephrussi & Hottinguer 1951) .
To disrupt the sturdy cell wall of yeast (comprising chitins, glucans and mannoproteins), Tony adapted physical methods for breaking open yeast cells without excessive disruption of intracellular membranes, using a shaker that abraded the yeast cells with glass beads, before isolating mitochondria by differential centrifugation. Later methods to break the yeast cells used in his laboratory in the late 1960s utilized a French press that was well suited to large-scale preparations of mitochondria. Later still, enzymatic digestion of the β-glucan polysaccharides of the cell wall followed by gentle osmotic lysis of the spheroplasts became widely used. His published reports demonstrated that the subcellular preparations were able to carry out respiratory processes characteristic of mitochondria, using the then available manometric and enzymological methods (1, 2)*.
Tony was initially very happy in Still's laboratory as he felt that he was being nurtured by his mentor, but a turning point came one day when Still remarked in Tony's presence that Tony would not amount to anything in science. Tony was mortified and felt not a little betrayed by those remarks, and this incident spurred him to achieve in no small way. In 1956, Tony married a local medical graduate, Judith Ann Neil, who later became a psychiatrist. After he had completed his PhD thesis that same year, they set off together to the USA for Tony's postdoctoral experience in the laboratory of David Green in Madison, Wisconsin. The door to his postdoctoral experience in Madison was opened by Still having spent a year in Green's laboratory some years earlier, during [1948] [1949] .
Postdoctoral work at the Institute for Enzyme Research in
Madison (1956) (1957) (1958) When Tony arrived at the Institute for Enzyme Research in Madison (the Enzyme Institute), Green was at the height of his research endeavours. His research programmes covered many core topics at the forefront of biochemistry research, including the detailed mechanism of the mitochondrial electron transport chain and oxidative phosphorylation (OXPHOS) (Beinert et al. 2004) . Tony joined research projects on mitochondrial bioenergetics, concerning the component enzyme systems of the mitochondrial respiratory electron transport chain. A series of oxidation-reduction steps takes place along this chain, catalysing the oxidation of substrates such as NADH through consumption of O 2 , as part of OXPHOS. As a result, mitochondria generate ATP from adenosine diphosphate (ADP), but the mechanism was not known at the time. The research aim was to systematically break down the mitochondria into functional components that could be eventually put back together to re-establish the full properties of intact mitochondria. In 1956, these biochemical approaches were being combined with newly developed electron microscopy techniques. Working on the so-called electron transport particles isolated from mitochondria, Tony published five papers from his two years at the Enzyme Institute on various aspects of the components of the mitochondrial electron transport and OXPHOS systems (3). Such approaches in Green's laboratory (and many others in the field at the time) produced lots of enzymological and morphological information about the workings of mitochondria, but never could solve the issue of how energy from respiratory electron transport was coupled mechanistically to the formation of ATP in mitochondria.
The search for the elusive chemical intermediate, conjectured by some biochemists in the field at the time to be a phosphorylated molecule of the putative form X∼P, was bound to be fruitless because the bioenergetically coupled systems of mitochondria (as with those of chloroplasts and bacterial cell membranes) were found some 10 years later to operate by chemiosmotic processes dependent on electrical charge separation across the closed biological * Numbers in this form refer to the bibliography at the end of the text.
membranes. These discoveries of Peter Mitchell (FRS 1974) , which earned him the Nobel Prize in chemistry in 1978, certainly disconcerted many of the mitochondrial research leaders of the 1950s and 1960s, as they had to give up their preconceived ideas. This is all thoughtfully described by Bill Slater FRS in his biographical memoir of Mitchell after the passing of the Nobel Laureate in 1992 (Slater 1994) .
His time at the Enzyme Institute was formative for Tony. He was inspired personally by David Green, whom he admired for his breadth of scientific vision and his ability to solve major research problems in biochemistry through the shrewd organization of his research teams to address significant issues. Moreover, Tony was thrilled to have met many internationally distinguished visitors who were, in his words, 'the mitochondrial giants of the day' (42). He also revelled in the weekly seminars given by local and national greats of biochemistry more generally. He made many friends in the Green laboratory, many of whom he would continue to meet and interact with at conferences over the next decades. He would maintain collaborations with a few of these colleagues many years later (especially Fred Crane).
Back in Sydney as a lecturer (1959) (1960) (1961) In 1959, Tony returned to the University of Sydney to take up a lectureship in biochemistry. He turned to yeast once again to research mitochondria, not only because it was a biological resource easy to obtain, but also because yeast could be manipulated physiologically as a facultative anaerobe and had a tractable genetic system. Thus, from work by Ephrussi & Hottinguer 1951 in France, mutants of S. cerevisiae were already known wherein mitochondrial function was compromised, namely the petite mutants, which had been shown to lack the mitochondrial cytochromes a, a 3 and b. These French studies had suggested that the genetic factor controlling the petite phenotype was cytoplasmically inherited controlled by a factor denoted rho. The inheritance pattern of rho was distinct from that of the genes of the nucleus, which were inherited in a strictly Mendelian fashion. In the mid 1950s rho was conjectured to be linked to deoxyribonucleic acid (DNA) in mitochondria, but it would be another decade before DNA in the mitochondria of yeast cells would first be definitively demonstrated (Schatz et al. 1964 ). Although such genetic and cellular properties of the petite mutant had been reported, definitive morphological and biochemical characterization of these respiratory-deficient mutants were yet to be carried out.
Tony's initial focus on return to Sydney was to characterize morphologically the mitochondria in yeast cells, in comparison with what had recently been observed in mammalian tissues. The first publication described work carried out with his first PhD student, Eberhard Vitols, on the overall morphology of cells of S. cerevisiae and their internal membranes and intracellular organelles, using an improved fixation procedure for electron microscopy (5). Further, Vitols and Tony were able for the first time to isolate preparations of intact yeast mitochondria that had some capacity of OXPHOS in laboratory experiments (4). They collaborated with staff at the Electron Microscope Unit of the University of Sydney, which had been established in 1958 (just a year before Tony's return to Sydney) under the directorship of D. G. Drummond.
Together with Vitols and another PhD student, Patricia Nowland, Tony published his first definitive paper on the properties of anaerobically grown yeast cells, this time using Torulopsis utilis (also known as Candida utilis) (6). This work showed that mitochondria normally seen in aerobically grown cells are converted, under anaerobiosis, into primitive structures that neither generate measurable respiration nor contain detectable mitochondrial cytochromes (nonetheless, the primitive entities contain two typical mitochondrial dehydrogenase enzymes). This system therefore had the potential for the systematic study of how mitochondria might be formed.
Tony made substantial progress in setting up his own laboratory, not only obtaining a grant from the National Health and Medical Research Council of Australia (NHMRC) for his research, but also gaining promotion to senior lecturer. Yet, Sydney was not the place where Tony could develop his laboratory, in part because of the constraining hand of Jack Still, as head of department, who preferred a department emphasizing teaching rather than research. The opportunity arose for Tony to join the recently established Department of Biochemistry at Monash University in Melbourne (where the foundation professor was Joseph Bornstein).
The highly productive yeast research years at Monash (1962 Monash ( -1980 The early years at Monash
In 1962, Tony was appointed as reader in biochemistry at Monash, where he commenced the realization of his vision to build a multidisciplinary research endeavour in a concerted attack on a major scientific problem: the biogenesis of mitochondria. His first approach to this problem was the use of anaerobically grown cultures of S. cerevisiae into which oxygen was introduced to demonstrate that functional mitochondria rapidly reappeared (7). This work was initially carried out by Patricia Wallace (née Nowland), who had come from Sydney to continue her PhD studies with Tony. Pat Wallace became the first female PhD graduate of Monash University after she submitted her thesis in 1965 (from Oxford, where she was working as a postdoctoral fellow in the laboratory of Sir Hans Krebs FRS). The electron microscopy work by Wallace was carried out at the University of Melbourne, where Neil C. R. Merrillees had an electron microscope in the Department of Anatomy. More detailed work on anaerobically grown yeast indicated that both catabolite repression (observed with glucose, as opposed to less repressing substrates such as galactose) and the availability of unsaturated fatty acids and sterols (both unable to be biosynthesized in the absence of oxygen) contributed to the abundance and enzyme composition of the mitochondrial membranes in anaerobically grown cells (9). David Jollow (a PhD student) carried out seminal work on defining the lipid composition of mitochondrial membranes in cells grown under various aerobic and anaerobic conditions (12).
Tony's successful research and participation in departmental leadership led to his promotion to professor in 1965, at the relatively young age of 35 (figure 2). He had participated in departmental teaching programmes as soon as he arrived, being one of the few academic staff members who had experience in undergraduate teaching (in his case, from the University of Sydney). During the period 1962-1965, Bornstein, Tony and others oversaw the design and construction of a new biochemistry building. A wide range of technical facilities for modern biochemistry research were established in the new building from 1965. For Tony's group on the second floor there were specialized facilities for large-scale microbial culture, including a large hydraulic press for use with so-called French press cylinders to break open the yeast cells, and an adjacent electron microscope suite. Elsewhere in the department was an analytical ultracentrifuge laboratory, under the supervision of Barry Preston, which was used for DNA and ribonucleic acid (RNA) research in Tony's group. In the mid 1960s, Tony commenced his seminal studies on the mechanisms whereby mitochondria are formed in cells. The first step was the demonstration that yeast mitochondria contain a protein-synthesizing system separate from that of the major population of ribosomes in the cell (known as cytoplasmic ribosomes). A team in Tony's laboratory comprising two PhD students, Minta Huang and Dick Biggs, and a postdoctoral fellow, Des ClarkWalker, discovered that the antibiotic chloramphenicol inhibits the formation of mitochondria in S. cerevisiae (8). The properties of the drug-treated cells were very similar to those of anaerobically grown yeast, both containing vestiges of mitochondria. A definitive publication shortly thereafter revealed great similarities between chloramphenicol-treated cells and the respiratory-deficient petite mutant (10). Here, the phrase 'biogenesis of mitochondria' appeared for the first time, in the title of a publication by Tony.
Over the next 20 years he published a remarkable series of 65 research articles under this generic title, plus many more without such a label, on a wide range of topics within this theme.
In 1967 Clark-Walker and Tony interpreted their observations to suggest that mitochondria are built up from proteins contributed separately by two protein-synthesizing systems: one is the 'conventional' cytoplasmic ribosomes translating nucleus-encoded mRNA, the other is the 'novel' mitochondrial ribosomal system that translates mRNA inside mitochondria, encoded by mitochondrial DNA (mtDNA). Adrian Lamb (a PhD student with Tony) soon showed that isolated yeast mitochondria are able to incorporate radioactive amino acids into protein, in a process that is inhibited by chloramphenicol, but not by cycloheximide, which inhibits the cytoplasmic ribosomes (13). This work was consolidated over the next few years with demonstrations of mitochondrial ribosomes in yeast with sedimentation properties different from those of cytoplasmic ribosomes. The concepts were extended to mammalian systems by a team led within Tony's group by Geoffrey Kellerman (a senior medically-qualified academic biochemist who had come from Sydney) (23).
Elucidation of major principles of mitochondrial genetics and the biogenesis of mitochondria
The study of antibiotic-resistant mutants of S. cerevisiae provided the breakthrough for Tony's laboratory to make definitive contributions to the molecular biology of mitochondria. The entrée to this work was facilitated by the visit of David Wilkie (a British yeast geneticist) to Monash in the mid 1960s. Wilkie had an interest in phenomena of drug resistance in S. cerevisiae and, during his stay at Monash, a series of mutants resistant to chloramphenicol, erythromycin or tetracycline were characterized for the degree of tolerance to each antibiotic and also for cross-resistance to these and other antibacterial antibiotics (11). The key erythromycin-resistant strain was that whose mitochondrial protein-synthesizing system showed insensitivity to this drug compared with that of wild-type yeast (14) . Subsequent genetic analysis of that mutant revealed the genetic determinant for erythromycin resistance to be inherited cytoplasmically, in an extrachromosomal manner (15). Elliot Gingold (a PhD student at Monash) clarified the relationship between the erythromycin resistance determinant (ER R ) and the genetic factor rho controlling the respiration-deficient petite phenotype (defined at the time as rho + in respiratory-competent cells and rho − in petite mutants). Gingold showed by a clever genetic test that the spontaneously arising petite derivatives from a parent rho + ER R strain often, but not always, retained the erythromycin resistance determinant (16) . However, treatment of these parent cells with strong inducers of petite mutants, euflavine or ethidium bromide, led to almost complete loss of the ER R determinant from the rho − cells generated by that drug. The notation ER 0 was first used to describe the loss of the erythromycin resistance determinant, as opposed to ER S and ER R for sensitivity or resistance, respectively (20) . The concept of differential loss of mitochondrial genetic information in petite mutants, presumed to arise from deletions within the mitochondrial genome, was a fundamental contribution to the field of yeast mitochondrial genetics.
Tony and colleagues made a further contribution that was seminal to the development of the mitochondrial genetics field, namely the concept of heteroplasmy whereby two (or more) different mitochondrial genomes can co-exist in the cytoplasm of the same cell (20) . Gary Saunders, a PhD student, analysed the mitochondrial genetic content of the progeny diploids formed by mating two rho + haploid yeast cells, one ER S and the other ER R . This entailed micromanipulation of the buds arising from the zygotes (the first cells arising after mating) and testing the colonies that were formed for their ability to grow in the presence of erythromycin. The patterns of mixed ER S and ER R genomes in the individual cells were inferred from the proportions of drug-sensitive and drug-resistant colonies. The variations in such patterns from zygote to zygote (and from successively generated buds) were interpreted to arise through the random reassortment among a population of multiple mitochondrial genomes in a single cell. Heteroplasmy is a fundamental idea that has stood the test of time and applies to most eukaryotic species including humans.
Tony's work up to the end of 1969 had made considerable advances on two other fronts. First was the detailed characterization of the mitochondrial structures in anaerobically grown cells, taken to much finer levels of morphological detail compared with earlier work owing to improved electron microscopy techniques (19) . Second was a thorough description of the role of mitochondrial protein synthesis in quantitative terms in normal and petite mutant cells under a variety of growth conditions (21) . The findings collectively cemented the notions elaborated some years earlier by Linnane that mitochondria are formed through the concerted biosynthetic programmes of the nucleus-coded general genetic system of the cell plus a specialized system inside mitochondria relying on the mitochondrial genome and its own dedicated protein synthesis system (much of which is generated by the main cellular nucleus-encoded system). These innovative concepts turned out to be applicable to mitochondria in all eukaryotes during the mid to late 1960s and also to apply to chloroplasts in the plant kingdom. It was, therefore, very timely that in December 1969 a major international conference entitled 'Autonomy and biogenesis of mitochondria and chloroplasts' was arranged through the energetic organizational skills of Tony and N. K. (Keith) Boardman (FRS 1978) (Division of Plant Industry, CSIRO, Canberra). This conference was held at the Australian Academy of Science in Canberra and was sponsored by that academy together with the US National Academy of Sciences and the International Union of Biochemistry (IUB). The conference proceedings (18) became a seminal volume in the field of organelle biogenesis.
One of the major outcomes of all the above contributions of Linnane to mitochondrial research, as represented by the substantial number and impressive content of his publications in the international literature, was his election as a fellow of the Australian Academy of Science in 1972.
The molecular definition of the yeast mitochondrial genome and mapping of the genes
The introduction of research directly on mtDNA and mitochondrial RNA in Tony's group commenced after the arrival of Phillip Nagley, who joined the research team as a PhD student in 1969. He discovered that petite mutant cells devoid of detectable mtDNA were generated after prolonged ethidium bromide treatment of the parent rho + cells (17) . The term rho 0 was introduced by Nagley and Tony for the mutant cells lacking mtDNA (22) . By contrast, rho − cells contain mtDNA, representing incomplete segments of mtDNA but at the same total abundance as in the parent rho + cells. This led to the important concept that rho − cells provided a biological system for the purification or cloning of segments of mtDNA which became amplified in inverse proportion to the amount of mitochondrial genetic information retained in each such petite strain (29) . Two further developments enabled Tony's laboratory to take the leading position in the international race to map the overall yeast mitochondrial genome. First, was the development of methods to enable the proportion of the rho + mitochondrial genome retained in the mtDNA of any given rho − strain to be accurately determined. A quantitative DNA-DNA hybridization method was developed by a postdoctoral fellow K. S. Sriprakash, working with Nagley (28) . The procedure also enabled the extent of sequence overlap between the residual mtDNA genomes of any two rho − mutants to be measured. Second, was the identification of several more mitochondrial genetic markers in S. cerevisiae. These included antibiotic resistance markers that encompassed a further series affecting mitochondrial ribosomes, including spiramycin, chloramphenicol and paromomycin (in addition to the erythromycin long studied by Linnane), and those affecting other enzymes complexes of mitochondria, including antimycin A (Complex III) and oligomycin (ATP synthase). Many (but not all) of these were first identified in Tony's laboratory, as reviewed in (29) . The antimycin A marker was first identified through another drug, mikamycin. Many PhD students (including Kaye Trembath, Peter Molloy and Rodney Devenish), working with Bruce Lukins, made significant contributions to these genetic analyses. The retention or loss of each of these genetic markers among collections of rho − mutants could be determined. The integration of these two factors led quickly to the unambiguous physical mapping of these markers onto a circular mitochondrial genome. It was thereby possible to locate the retained segment of mtDNA in each rho − strain in relation to the particular antibiotic resistance markers that it had retained or lost (28) .
A further major addition to mitochondrial genetics in the mid 1970s, just as the development of physical mapping techniques came to fruition, was the identification of mit − mutants, defined by Slonimski & Tzagoloff (1976). These are defective in a single mitochondrial enzyme complex and contain a point mutation or small deletion in mtDNA (but not the major deletions characteristic of rho − mutants). A driving force for the isolation of such mit − mutants in Tony's group was a visiting Polish scientist, Joanna Rytka, who devised a clever mutagenesis, selection and clonal purification strategy for novel mit − isolates. By genetically testing these mit − strains in crosses to the panel of mapped rho − petites, the map position of the new mit − locus could be readily determined. Further, by biochemical analysis of the mit − mutant cells grown in bulk (cytochrome content and enzyme activities), it was possible to determine which of the respiratory complexes was primarily affected by the mit − mutation (27). These additional genetic markers, together with further molecular markers (namely, the two mitochondrial ribosomal RNA (rRNA) genes, studied by RNA-DNA hybridization techniques with mtDNA from the panel of mapped rho − petites), were incorporated into the physical map of mtDNA; the first comprehensive map of the mitochondrial genome of yeast was thereby generated (26). These insights into the physical placement of genes in the circular yeast mitochondrial genome were all the more remarkable because the map derived at Monash was congruent with the fragmentary maps that were being built up by other laboratories in the USA and Europe, based on the application of restriction enzyme analysis to the mtDNA of smaller series of rho − collections carrying defined genetic markers.
Biochemical studies from 1970 focused on the membranes of mitochondria, particularly using techniques to alter the lipid composition of the inner mitochondrial membrane. This was achieved primarily by use of a fatty acid desaturase mutant of S. cerevisiae (ole1) and manipulation of the concentrations of unsaturated fatty acids provided in the culture media. A powerful tool to study membrane-associated enzyme systems in mitochondria containing various levels of unsaturated fatty acids was introduced by means of Arrhenius plots, which involve measurements of the change of activity of a particular function with temperature. The approach was first applied in collaboration with John K. Raison (CSIRO Plant Physiology Unit, Sydney) on mitochondrial protein synthesis in rat liver, in work carried out by Neale Towers (a PhD student) together with Kellerman (24) . This study showed elegantly that mitochondrial ribosomes are membrane-associated. This approach was soon applied to yeast mitochondrial protein synthesis by Sangkot Marzuki (PhD student), who used chemostat cultures of the ole1 mutant to generate bulk quantities of cells containing particular levels of unsaturated fatty acids (25) . The biochemical analyses of this work were overseen in the laboratory by James (Jim) Haslam, a lecturer from the UK. These studies not only confirmed the functional association of yeast mitochondrial ribosomes with the mitochondrial membranes, but also showed that a minimal threshold of 28% of unsaturated fatty acids was required for the mitochondrial protein synthesis system to function at all. This type of work was extended to encompass DNA synthesis in isolated mitochondria by John Mattick (PhD student) and Ruth Hall (postdoctoral fellow), which was also shown to be a membrane-associated function. Terry Spithill (PhD student) carried out further work on characterizing the mitochondrial ribosomes in wild-type and various mutant yeast strains.
In recognition of Tony's pioneering achievements on mitochondrial biogenesis, primarily in yeast, in 1980 he was elected a Fellow of the Royal Society, London; he was then at the peak of his scientific career (figure 3).
From a personal point of view, Tony's family had grown by the arrival of two children, Ruth in 1967 and Nicholas (Nick) in 1972; however, in 1978 he and Judith separated. After their divorce, Tony married again in 1980, to Daryl Ann Woods. His marriage with Daryl, which lasted until his death 37 years later, had implications for Tony's professional life in relation to his establishment of the Centre for Molecular Biology and Medicine (CMBM). Contact with business colleagues of Daryl's father Alan Skurrie, a prominent company director, enabled Tony to be introduced to powerful high echelons of Melbourne's business world. Tony founded CMBM in 1983 based on solid external private funding for projects with medical application and prospects for commercialization. In addition to the research on mitochondria and ageing outlined below, Tony worked within CMBM on the development of strategies for amelioration of deleterious effects of ageing using redox-active substances such as coenzyme Q (CoQ). He also carried out research within CMBM, at various times, on both human interferons and mucinous cancer antigens. CMBM separated from Monash in 1996 and eventually closed in 2008. 
From yeast mitochondria to human ageing (1981-2008)
Adenosine triphosphate synthase The yeast research now concentrated on mitochondrial ATP synthase, continuing work commenced in the late 1970s. Adenosine triphosphate synthase is responsible for ATP formation during OXPHOS, by pumping of protons through the membrane-embedded F o sector of the complex.
John E. Walker FRS and Paul D. Boyer shared the Nobel Prize in 1997 for their elucidation of the detailed molecular structure and mechanism of the soluble F 1 component of the complex which catalyses the synthesis of ATP from ADP plus inorganic phosphate (or the reverse ATPase reaction, namely ATP hydrolysis). However, the detailed molecular structure and proton-pumping mechanism of the membrane-embedded F o sector remain the subject of active research to the present time.
Two of the membrane-associated proteins of the complex (as known when this work started) were coded by mtDNA, namely subunits 9 and 6, encoded by the oli1 and oli2 genes respectively (30, 31) . The remaining 10 or more subunits are encoded by nuclear genes, the proteins being imported into mitochondria, where they assemble into the complex. Tony and colleagues (figure 4) focused on the genetics and assembly of the enzyme complex. The genetical studies were overseen by Lukins and the work on biochemistry and assembly of the complex was led by Marzuki. The DNA sequencing analyses that took place under Nagley's supervision enabled detailed specification of the sites of mutation conferring resistance to oligomycin and other drugs, as well as those causing mit − mutations blocking assembly or function of the complex. In 1982 a third gene in yeast mtDNA encoding a subunit of ATP synthase was discovered, namely the aap1 gene encoding subunit 8 (32). This subunit is thought to be an ancillary protein spanning the inner mitochondrial membrane, alongside the other two subunits, 9 and 6, directly involved in the proton channel (Nagley 1988 ).
Mitochondria and ageing
Tony became interested in the role of mitochondria in human ageing through contact with Edward Byrne, who was the director of neurology at St Vincent's Hospital in Melbourne and had a research interest in mitochondrial myopathies. Marzuki, who had a medical background, had initiated these interactions as his own interest in mitochondrial diseases developed in the mid 1980s.
Tony had a colleague in Japan, Takayuki Ozawa (University of Nagoya), with whom he had interacted at mitochondrial conferences. In the late 1980s, Tony and Ozawa began to have discussions on the generality of the mutations in human mtDNA that had been described to occur in various mitochondrial diseases. Prior research had led to the recognition that in many mitochondrial myopathies, the mtDNA in muscles of the patients carried a pronounced frequency of molecules carrying a deletion of 4977 base pairs (known as mtDNA 4977 ). Familiar with the genetic properties of petite mutant yeast cells containing mtDNA carrying deletions and their properties including heteroplasmy, Tony interpreted in 'yeast terms' the emerging literature on the properties of mtDNA mutations in humans, especially those of the mtDNA 4977 genotype. He extended these ideas to the ageing process in terms of the progressive shifts that can occur over time in the proportion of mutant mtDNA relative to normal mtDNA. Together with Marzuki (at Monash) and Masashi Tanaka (a postdoctoral researcher with Ozawa at Nagoya), the seminal proposals of the role of mtDNA mutations in ageing and degenerative diseases were published by Tony and Ozawa in the Lancet in 1989 (33) . This turned out to be a landmark publication in the field of mitochondrial involvement in ageing and became the most highly cited of Tony's publications over his entire career (more than 900 times, nearly three times more frequently than his next most cited article (38) ). The proposals made in this article were supported by an accompanying article in the Lancet from Byrne and Marzuki reporting an age-related decline in mitochondrial function in human muscle biopsy samples (Trounce et al. 1989) .
Tony and his Monash colleagues described the variety of mtDNA mutations in various human tissues during ageing in a long series of publications. The first reported in 1990 that the mtDNA 4977 genotype was detected by the polymerase chain reaction (PCR) in relatively large amounts (up to 1% of total mtDNA) in all adult tissues examined (including skeletal muscle, cardiac muscle and brain) (34). In contrast, mtDNA 4977 was found in much less abundance in corresponding tissues from infants, indicating that the accumulation of mtDNA 4977 is not necessarily associated with particular mitochondrial diseases, but occurs in all individuals with increasing frequency during normal ageing. The human tissues used by Tony and colleagues at Monash were obtained from autopsy samples at the Victorian Institute of Forensic Medicine in South Melbourne, through the good offices of Professor Stephen Cordner. Strict adherence to Human Ethics protocols was required for access to, and use of, these tissues in this research.
Further work went on to characterize different types of age-associated mtDNA deletions. One highly cited paper from Tony's group (led by Chunfang Zhang, a postdoctoral researcher from China, working with Nagley) reported multiple types of mtDNA deletions in individual tissues of a single human subject (36); the subject had no mitochondrial disease. DNA sequencing analysis of PCR products showed that short direct repeat sequences (5 to 13 bp) flanked all deletion breakpoints; in most cases one copy of the repeat was deleted. This suggested the mechanism of formation of deletions was an error in mtDNA replication (such as template switching across the homologous sequences) but this has been very difficult to prove. Another avenue of research in Tony's laboratory emphasized the accumulation of point mutations in mtDNA during ageing (37) .
It was, however, more difficult to demonstrate that the mtDNA mutations accumulating with age causally diminished mitochondrial function. At CBM Tony pursued this proposition by examining accumulation of mtDNA mutations with age using novel PCR methods (termed 'extra-long PCR', to capture the range of mtDNA deletions displayed by agarose gel electrophoresis) and correlating the results with the observed depletion of cytochrome oxidase activity in skeletal muscle, where a mosaic of normal and functionally depleted fibres could be seen to accumulate with age (40) . Further work, carried out by Sergey Kovalenko (a Russian postdoctoral researcher with Tony, who had previously worked with Tanaka and Ozawa in Japan), enabled the development of PCR amplification procedures to quantify mtDNA 4977 in individual muscle fibres (39). This method was extended to utilize the 'extra-long PCR' in these experiments; the accumulation of mtDNA mutations (termed mtDNA rearrangements) with loss of mitochondrial function in skeletal muscle fibres (measured by cytochrome oxidase staining) was thereby correlated (41). Tony was not, of course, alone in this field and many other authors had contributed to the development of the ideas that linked accumulated damage to mtDNA through oxidative stress mechanisms and other forms of mutational damage to the loss of bioenergetic functions and tissue damage that could also lead to cell death.
Information on mitochondrial involvement in cell death emerged during the 1990s from studies on the mechanism of apoptosis (programmed cell death, whereby the cell activates internal pathways to suicide), which implicated mitochondria in hitherto unanticipated ways. In 1994, it was directly demonstrated by Tony's group that respiratory chain inhibitors could induce apoptosis (cell death) in cultured human cells (38) . Although the detailed mechanism of this was not clear at that time, this observation directed attention to the possibly lethal consequences to cells of mitochondrial functional deficits caused by mtDNA mutations as part of the ageing process.
In order to express these new ideas neatly, Tony introduced the theme 'the universality of bioenergetic disease' to encompass his newly emergent research vision (35). He was also much taken with the idea of ameliorating the bioenergetic defects in cells that evidently arose during ageing. He considered that one needed to understand in more detail the biochemical and physiological roles of molecules with redox activity, such as CoQ, and, from those understandings, to derive rational approaches to pharmacological therapies; but he disavowed the prevailing ideas of his international colleagues that CoQ acted strictly as an anti-oxidant (42). Tony was never able to realize his objective to develop fully a bioenergetically-based strategy for ameliorating aspects of ageing. 
Summation of research achievements

Personal reflections
In the half century that I knew Tony Linnane, as student, academic colleague and friend, I came to know well his strengths and other features of his complex personality. He was a highly accomplished insightful scientist in his productive years and was able to build up outstanding teams under his direction at various times in his career. He encouraged and supported many of his colleagues and subordinates in matters concerning career development, fellowships, academic appointment or promotion. When such backing was not reciprocated (as was the case with some of those whom he had encouraged), he felt disappointed and betrayed. Tony's feeling that he was not appreciated suitably by his peers fuelled his intense desire for recognition, especially later in life. He had been much influenced by the way in which the bioenergetics field was revolutionized in the 1960s by an 'outsider', Peter Mitchell, who had pursued his ideas in the face of entrenched opposition from a mainstream scientific community that had collectively missed a major feature of the OXPHOS system they had been studying for many years (this led to Mitchell eventually receiving a Nobel Prize in 1978; see above). In later life, Tony thought of himself as such an outsider in the ageing field and, in his view, the misplaced ideas of his international colleagues would not eventually lead to clinical successes; he thought that such successes could only arise according to his alternative standpoint.
Tony had a charming and gracious side that served him well in making contacts at all levels of professional and personal life. In the most recent decades (figure 5) he enjoyed many happy times with his family, often travelling overseas with his second wife, Daryl, together with his stepchildren (Daniel Woods, born 1969, and Kristen Woods, born 1970) and his son, Nick. Tony took great delight in explaining the historical aspects of places they visited together or in selecting the most appropriate wine to drink at many a fine restaurant around the world. As the personal beneficiary of such cultural and historical mentoring on several occasions during attendance at conferences in Europe or the USA, I can well appreciate the scientist and the often larger than life personality that was Tony Linnane. 
Honours and Awards
